C. Himeda

发表

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy

O. King, K. Wagner, C. Emerson, 2015, Clinical Epigenetics.

Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer.

C. Emerson, M. Barro, C. Himeda, 2013, Developmental biology.

Quantitative Proteomic Identification of Six4 as the Trex-Binding Factor in the Muscle Creatine Kinase Enhancer

R. Aebersold, J. Ranish, P. Maire, 2004, Molecular and Cellular Biology.

Transgenic and tissue culture analyses of the muscle creatine kinase enhancer Trex control element in skeletal and cardiac muscle indicate differences in gene expression between muscle types

S. Hauschka, C. Himeda, Quynh G Nguyen, 2003, Transgenic Research.

Differences in the Function of Three Conserved E-boxes of the Muscle Creatine Kinase Gene in Cultured Myocytes and in Transgenic Mouse Skeletal and Cardiac Muscle*

S. Hauschka, C. Himeda, Quynh G Nguyen, 2003, Journal of Biological Chemistry.

FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?

Peter L Jones, C. Himeda, 2022, Journal of personalized medicine.

Quantitative Proteomic Identiﬁcation of MAZ as a Transcriptional Regulator of Muscle-Speciﬁc Genes in Skeletal and Cardiac Myocytes (cid:1)

J. Ranish, S. Hauschka, C. Himeda, 2008 .

Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy

Peter L Jones, T. Jones, C. Himeda, 2017, Neuromuscular Disorders.

Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies.

Peter L Jones, T. Jones, C. Himeda, 2016, Trends in pharmacological sciences.

Implication of Interfering Antibody Formation and Apoptosis as Two Different Mechanisms Leading to Variable Duration of Adenovirus-Mediated Transgene Expression in Immune-Competent Mice

M. Kay, Christopher B Wilson, D. Schowalter, 1999, Journal of Virology.

Expression in Immune-Competent Mice of Adenovirus-Mediated Transgene Mechanisms Leading to Variable Duration Formation and Apoptosis as Two Different Implication of Interfering Antibody

M. Kay, Christopher B Wilson, D. Schowalter, 1999 .

Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD

Peter L Jones, T. Jones, C. Himeda, 2020, Molecular therapy. Methods & clinical development.

Myogenic Enhancers Regulate Expression of the Facioscapulohumeral Muscular Dystrophy-Associated DUX4 Gene

M. Beermann, Peter L Jones, T. Jones, 2014, Molecular and Cellular Biology.

Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Peter L Jones, T. Jones, C. Himeda, 2014, Antioxidants & redox signaling.

Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy

Michael R. Green, L. Zhu, Peter L Jones, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Eomesodermin is a localized maternal determinant required for endoderm induction in zebrafish.

G. Farr, D. Kimelman, Y. Kikuchi, 2005, Developmental cell.

CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.

Peter L Jones, T. Jones, C. Himeda, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy.

Peter L Jones, C. Himeda, 2019, Annual review of genomics and human genetics.

Analysis of muscle gene transcription in cultured skeletal muscle cells.

S. Hauschka, C. Himeda, P. Tai, 2012, Methods in molecular biology.

Quantitative Proteomic Identification of Six4 as the Trex-Binding Factor in the Muscle Creatine Kinase Enhancer

R. Aebersold, J. Ranish, P. Maire, 2004, Molecular and Cellular Biology.

Inhibition of NF-κB Activation in Combination with Bcl-2 Expression Allows for Persistence of First-Generation Adenovirus Vectors in the Mouse Liver

M. Kay, A. Lieber, L. Meuse, 1998, Journal of Virology.

Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.

J. Chamberlain, L. Meuse, P. Gregorevic, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

The Good, The Bad, and The Unexpected: Roles of DUX4 in Health and Disease.

Peter L Jones, C. Himeda, 2019, Developmental cell.

Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer

A. P. Mackenzie, B. Wold, Katherine I. Fisher-Aylor, 2011, Skeletal Muscle.

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy

O. King, K. Wagner, C. Emerson, 2015, Clinical Epigenetics.

Quantitative Proteomic Identification of MAZ as a Transcriptional Regulator of Muscle-Specific Genes in Skeletal and Cardiac Myocytes

J. Ranish, S. Hauschka, C. Himeda, 2008, Molecular and Cellular Biology.

Proteomic Strategies for Understanding Cardiac Function, Development, and Disease

S. Hauschka, C. Himeda, 2010 .

Facioscapulohumeral Muscular Dystrophy: Unraveling the Mysteries of a Complex Epigenetic Disease

C. Emerson, C. Himeda, 2012 .

KLF3 Regulates Muscle-Specific Gene Expression and Synergizes with Serum Response Factor on KLF Binding Sites

J. Ranish, M. Crossley, Richard C. M. Pearson, 2010, Molecular and Cellular Biology.

Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles.

S. Hauschka, C. Himeda, Xiaolan Chen, 2011, Methods in molecular biology.

Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy

Peter L Jones, T. Jones, C. Himeda, 2017, Neuromuscular Disorders.